Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
The current price of CLBT is $15.46 USD — it has decreased by -2.35% in the past 24 hours. Watch Cellebrite DI stock price performance more closely on the chart.
What is Cellebrite DI stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Cellebrite DI stocks are traded under the ticker CLBT.
Is Cellebrite DI stock price growing?▼
CLBT stock has fallen by -0.69% compared to the previous week, the month change is a +26.94% rise, over the last year Cellebrite DI has showed a +8.87% increase.
What is Cellebrite DI market cap?▼
Today Cellebrite DI has the market capitalization of 3.95B
When is the next Cellebrite DI earnings date?▼
Cellebrite DI is going to release the next earnings report on August 12, 2026.
What were Cellebrite DI earnings last quarter?▼
CLBT earnings for the last quarter are 0.04 USD per share, whereas the estimation was 0.05 USD resulting in a -25.61% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cellebrite DI revenue for the last year?▼
Cellebrite DI revenue for the last year amounts to 475.68M USD.
What is Cellebrite DI net income for the last year?▼
CLBT net income for the last year is 78.33M USD.
How many employees does Cellebrite DI have?▼
As of July 17, 2026, the company has 1,167 employees.
In which sector is Cellebrite DI located?▼
Cellebrite DI operates in the Technology sector.
When did Cellebrite DI complete a stock split?▼
Cellebrite DI has not had any recent stock splits.
Where is Cellebrite DI headquartered?▼
Cellebrite DI is headquartered in Petah Tikva, Israel.